Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective. (2021)

First Author: Mackie SL
Attributed to:  MICA: Treatment According to Response in Giant cEll arTeritis (TARGET) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2665-9913(20)30386-6

PubMed Identifier: 33521671

Publication URI: http://europepmc.org/abstract/MED/33521671

Type: Journal Article/Review

Volume: 3

Parent Publication: The Lancet. Rheumatology

Issue: 1

ISSN: 2665-9913